Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (synercid) compared to its susceptibilities to reference macrolides and quinolones

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 4, 2002, Pages 1114-1116

  Bråbäck, Martin ^a   Riesbeck, Kristian ^a   Forsgren, Arne ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; QUINOLONE DERIVATIVE; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ACETAMIDES; ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; OXAZOLIDINONES; VIRGINIAMYCIN;

EID: 0036211724     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.4.1114-1116.2002     Document Type: Article

References (20)

1. Antibiotic susceptibility pattern of Mycobacterium marinum
2. Clarithromycin: A potent agent against infections due to Mycobacterium marinum
3. Linezolid
4. Mycobactcrium marinum infections in men
5. Mycobacterium marinum skin infections. Report of 31 cases and review of literature
6. Mycobacterium marinum wrist arthritis: Local and systemic dissemination caused by concomitant immunosuppressive therapy
7. In vitro susceptibilites of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials
8. Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates
9. Antibiotic susceptibility of Mycobacterium marinum
10. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin
11. Activity of moxifloxacin against mycobacteria
12. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum
13. Mycobacterium balnei: A new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans
14. In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4
15. In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs
16. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
17. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex
18. Diagnostic and treatment of disease caused by nontuberculous mycobacteria
19. Activities of linezolid against rapidly growing mycobacteria
20. Antimicrobial susceptibility of Mycobacterium marinum determined by Etest and agar dilution